Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

Abstract Background Long-acting injectable (LAI) antipsychotics use is associated with improved adherence which can reduce the rate of relapse, hospitalization, and associated costs in patients with schizophrenia. Young adults could be at higher risk of poor adherence, hence use of LAI in this popul...

Full description

Bibliographic Details
Main Authors: Alex Z. Fu, Jacqueline A. Pesa, Susan Lakey, Carmela Benson
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Psychiatry
Subjects:
Schizophrenia
Long acting injectables
Hospitalization
Relapse
Healthcare resource utilization and costs
Online Access:https://doi.org/10.1186/s12888-022-03895-2

Internet

https://doi.org/10.1186/s12888-022-03895-2

Similar Items